XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue:        
Total revenue $ 299 $ 0 $ 299 $ 0
Operating expenses:        
Research and development 12,946 13,130 25,882 24,332
General and administrative 4,388 6,953 11,239 14,125
Total operating expenses 17,334 20,083 37,121 38,457
Loss from operations (17,035) (20,083) (36,822) (38,457)
Other income:        
Interest income 1,143 1,608 2,419 3,154
Other income 143 62 310 135
Total other income, net 1,286 1,670 2,729 3,289
Loss before equity in losses of joint venture (15,749) (18,413) (34,093) (35,168)
Loss on investment in joint venture 487 217 1,172 780
Net loss $ (16,236) $ (18,630) $ (35,265) $ (35,948)
Net loss per common share, basic (in dollars per share) $ (0.37) $ (0.46) $ (0.83) $ (0.89)
Net loss per common share, diluted (in dollars per share) $ (0.37) $ (0.46) $ (0.83) $ (0.89)
Weighted-average common shares outstanding, basic (in shares) 44,128,059 40,363,902 42,450,837 40,306,715
Weighted-average common shares outstanding, diluted (in shares) 44,128,059 40,363,902 42,450,837 40,306,715
Other comprehensive loss:        
Net unrealized loss on marketable securities $ 0 $ (211) $ (86) $ (58)
Other comprehensive loss 0 (211) (86) (58)
Comprehensive loss (16,236) (18,841) (35,351) (36,006)
Collaboration and license revenue        
Revenue:        
Total revenue $ 299 $ 0 $ 299 $ 0